IL-7Rα and E47:: independent pathways required for development of multipotent lymphoid progenitors

被引:47
|
作者
Kee, BL [1 ]
Bain, G [1 ]
Murre, C [1 ]
机构
[1] Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA
来源
EMBO JOURNAL | 2002年 / 21卷 / 1-2期
关键词
E47; IL-7R alpha; lymphopoiesis; multipotent lymphoid progenitors;
D O I
10.1093/emboj/21.1.103
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mice that lack the transcription factors encoded by the E2A gene or the receptor for interleukin 7 (IL-7R) have severe overlapping defects in lymphocyte development. Here, we show that E2A proteins are required for the survival of early T-lineage cells; however, they function through a pathway that is distinct from the survival pathway initiated by IL-7R signaling. While E2A proteins are required to suppress caspase 3 activation, ectopic expression of the antiapoptotic protein Bcl-2 is not sufficient to overcome the lymphopoietic defects observed in the absence of E2A. Remarkably, mice that lack both IL-7Ralpha and E47 display a synergistic decrease in the number of T-cell, NK-cell and multipotent progenitors in the thymus, indicating that these distinct survival pathways converge to promote the development of multipotent lymphoid progenitors.
引用
收藏
页码:103 / 113
页数:11
相关论文
共 50 条
  • [21] Liver X receptor β is required for the survival of single-positive thymocytes by regulating IL-7Rα expression
    Huang Huang
    Xiaoping Wu
    Dongwei Meng
    Yizhou Feng
    Lan Zhou
    Zhenyu Liu
    Shupei Tang
    Xueqin Li
    Yi Cao
    Haiyang He
    Zhunyi Xie
    Jingbo Zhang
    Yongwen Chen
    Tingting Zhao
    Yuzhang Wu
    Xinyuan Zhou
    Cellular & Molecular Immunology, 2021, 18 : 1969 - 1980
  • [22] Selective ablation of the YxxM motif of IL-7Rα suppresses lymphomagenesis but maintains lymphocyte development
    L C Osborne
    K A Duthie
    J H Seo
    R D Gascoyne
    N Abraham
    Oncogene, 2010, 29 : 3854 - 3864
  • [23] Selective ablation of the YxxM motif of IL-7Rα suppresses lymphomagenesis but maintains lymphocyte development
    Osborne, L. C.
    Duthie, K. A.
    Seo, J. H.
    Gascoyne, R. D.
    Abraham, N.
    ONCOGENE, 2010, 29 (26) : 3854 - 3864
  • [24] Identification of novel lymphoid tissues in murine intestinal mucosa where clusters of c-kit(+) IL-7R(+) Thy1(+) lympho-hemopoietic progenitors develop
    Kanamori, Y
    Ishimaru, K
    Nanno, M
    Maki, K
    Ikuta, K
    Nariuchi, H
    Ishikawa, H
    JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04): : 1449 - 1459
  • [25] The pivotal role of Il-7/Il-7r-dependent signaling pathway for expansion of highly Il-7r expressing mucosal T cells and development of chronic colitis
    Okada, E
    Yamazaki, M
    Nakamura, T
    Kanai, T
    Tanabe, M
    Takeuchi, T
    Watanabe, M
    GASTROENTEROLOGY, 2004, 126 (04) : A426 - A426
  • [26] Blocking of IL-7R signaling prevents the development of Helicobacter felis-induced gastritis in mice
    Ohana, M
    Okazaki, K
    Nishi, T
    Uchida, K
    Uose, S
    Nakase, H
    Chiba, T
    GASTROENTEROLOGY, 2001, 120 (05) : A513 - A513
  • [27] Overexpression of IL-7Rα provides a competitive advantage during early T-cell development
    Laouar, Y
    Crispe, IN
    Flavell, RA
    BLOOD, 2004, 103 (06) : 1985 - 1994
  • [28] Selective ablation of the YxxM motif of IL-7R alpha suppresses lymphomagenesis but maintains lymphocyte development
    Osborne, Lisa
    Duthie, Kia A.
    Gascoyne, Randy
    Abraham, Ninan
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [29] Proteomics analysis of interleukin (IL)-7-induced signaling effectors shows selective changes in IL-7Rα449F knock-in T cell progenitors
    Duthie, Kia A.
    Osborne, Lisa C.
    Foster, Leonard J.
    Abraham, Ninan
    MOLECULAR & CELLULAR PROTEOMICS, 2007, 6 (10) : 1700 - 1710
  • [30] The Tetraspanin CD53 Regulates Early B Cell Development by Promoting IL-7R Signaling
    Greenberg, Zev J.
    Monlish, Darlene A.
    Bartnett, Rachel L.
    Yang, Yihu
    Shen, Guomin
    Li, Weikai
    Bednarski, Jeffrey J.
    Schuettpelz, Laura G.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01): : 58 - 67